Loading stock data…
Avantor, Inc. (AVTR)
$10.03-0.25 (-2.43%)
Market ClosedLast close Jun 29
Avantor, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Avantor, Inc. in the Healthcare sector is trading at $10.03 with a market capitalization of $6.2B. Wall Street consensus targets $9.78 (16 analysts), implying a -2.5% move over the next 12 months. The stock is currently 37% below its 52-week high of $15.93, remaining 3.7% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.58B↓ | $1.66B↑ | $1.62B↓ | $1.68B↑ | $1.58B |
| Gross Profit | $500.70M↓ | $523.90M↓ | $526.50M↓ | $554.10M↑ | $534.90M |
| Operating Income | $99.50M↓ | $131.50M↓ | $136.20M↑ | $128.80M↓ | $147.40M |
| Net Income | $43.30M↓ | $52.40M↑ | -$711.80M↓ | $64.70M↑ | $64.50M |
Peer Comparison
JNJUNHPFE
Fundamentals
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle Ea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$6.19B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.94
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.87%
Volume
Today's trading volume
7.68M
Recent News
3 Value Stocks with Questionable Fundamentals
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Why Avantor (AVTR) Stock Is Up Today
Shares of life sciences company Avantor (NYSE:AVTR) jumped 3.2% in the morning session after an analyst at Barclays boosted their price target on the stock and the company formally concluded its CFO transition on June 24, removing a governance concern.
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Q1 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Avantor (NYSE:AVTR) and its peers.